Join
Live feed
·
PRReleasevia Quantisnow
Greenwich LifeSciences Inc. logo

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

ByQuantisnow·Wall Street's wire, on your screen.
GLSI· Greenwich LifeSciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLSI (Greenwich LifeSciences Inc.) and more on Quantisnow.